Maria Paz Queipo De Llano

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

Marta Pratcorona, Salut Brunet, Josep Nomdedéu et al. · Blood · 2013 · 282 citations

Medicine, Hematology, Oncology +12

Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]

G Perea, Adriana Lasa, Neus Villamor et al. · Leukemia · 2005 · 160 citations

Medicine, Hematology, Oncology +17

The lincRNA<i>HOTAIRM1</i>, located in the<i>HOXA</i>genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

Marina Díaz‐Beyá, Salut Brunet, Josep Nomdedéu et al. · Oncotarget · 2015 · 130 citations · Full text

Life Sciences, Genetics, Oncology +17

Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells

Luz Muñoz, Josep Nomdedéu, Neus Villamor et al. · Leukemia · 2003 · 110 citations

Medicine, Hematology, Oncology +17

Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML

Josep Nomdedéu, Montserrat Hoyos, Maite Carricondo et al. · Leukemia · 2013 · 73 citations

Medicine, Hematology, Oncology +10